HUP0900130A3 - Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation - Google Patents

Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation

Info

Publication number
HUP0900130A3
HUP0900130A3 HU0900130A HUP0900130A HUP0900130A3 HU P0900130 A3 HUP0900130 A3 HU P0900130A3 HU 0900130 A HU0900130 A HU 0900130A HU P0900130 A HUP0900130 A HU P0900130A HU P0900130 A3 HUP0900130 A3 HU P0900130A3
Authority
HU
Hungary
Prior art keywords
benzoxazole
dihydro
amorphous
processes
preparation
Prior art date
Application number
HU0900130A
Other languages
English (en)
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HU0900130A priority Critical patent/HUP0900130A3/hu
Priority to EP10710897A priority patent/EP2403850A1/en
Priority to PCT/HU2010/000023 priority patent/WO2010100512A1/en
Priority to US13/147,181 priority patent/US20120059034A1/en
Priority to EA201101248A priority patent/EA201101248A1/ru
Priority to CN2010800098457A priority patent/CN102341392A/zh
Priority to JP2011552532A priority patent/JP2012519680A/ja
Priority to CA2750010A priority patent/CA2750010A1/en
Publication of HUP0900130A2 publication Critical patent/HUP0900130A2/hu
Publication of HUP0900130A3 publication Critical patent/HUP0900130A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0900130A 2009-03-03 2009-03-03 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation HUP0900130A3 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
HU0900130A HUP0900130A3 (en) 2009-03-03 2009-03-03 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
EP10710897A EP2403850A1 (en) 2009-03-03 2010-03-01 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
PCT/HU2010/000023 WO2010100512A1 (en) 2009-03-03 2010-03-01 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for them preparation
US13/147,181 US20120059034A1 (en) 2009-03-03 2010-03-01 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
EA201101248A EA201101248A1 (ru) 2009-03-03 2010-03-01 Новые кристаллогидратные, аморфная и полиморфные формы производного дигидробензоксазол-6-илацетамида и способы их получения
CN2010800098457A CN102341392A (zh) 2009-03-03 2010-03-01 二氢苯并噁唑-6-基-乙酰胺衍生物的新的结晶水合物、无定形和多晶型形式及其制备方法
JP2011552532A JP2012519680A (ja) 2009-03-03 2010-03-01 ジヒドロベンゾオキサゾール−６−イル−アセトアミド誘導体の新規結晶性水和物、非晶質体、多形体およびその調製プロセス
CA2750010A CA2750010A1 (en) 2009-03-03 2010-03-01 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0900130A HUP0900130A3 (en) 2009-03-03 2009-03-03 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation

Publications (2)

Publication Number Publication Date
HUP0900130A2 HUP0900130A2 (en) 2011-03-28
HUP0900130A3 true HUP0900130A3 (en) 2012-02-28

Family

ID=89988819

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0900130A HUP0900130A3 (en) 2009-03-03 2009-03-03 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation

Country Status (8)

Country Link
US (1) US20120059034A1 (hu)
EP (1) EP2403850A1 (hu)
JP (1) JP2012519680A (hu)
CN (1) CN102341392A (hu)
CA (1) CA2750010A1 (hu)
EA (1) EA201101248A1 (hu)
HU (1) HUP0900130A3 (hu)
WO (1) WO2010100512A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3228004A1 (en) 2021-08-06 2023-02-09 Marie Genin Formulations of radiprodil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20000728A1 (es) 1998-06-26 2000-08-21 Cocensys Inc Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
IL159393A (en) 2001-07-24 2011-01-31 Richter Gedeon Vegyeszet Piperidine derivatives, pharmaceutical compositions containing them, processes for their preparation and uses thereof
WO2010006020A1 (en) * 2008-07-08 2010-01-14 Forest Laboratories Holdings Limited Novel crystalline form of 2-[4(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide

Also Published As

Publication number Publication date
WO2010100512A8 (en) 2011-07-21
WO2010100512A1 (en) 2010-09-10
CN102341392A (zh) 2012-02-01
CA2750010A1 (en) 2010-09-10
US20120059034A1 (en) 2012-03-08
EP2403850A1 (en) 2012-01-11
EA201101248A1 (ru) 2012-02-28
JP2012519680A (ja) 2012-08-30
HUP0900130A2 (en) 2011-03-28

Similar Documents

Publication Publication Date Title
HK1254977A1 (zh) 索非布韋(sofosbuvir)的結晶形式
SI2634191T1 (sl) Postopek za pripravo derivatov tienopirimidindiona
EP2477628A4 (en) PREPARATION OF CRYSTALLINE FORMS OF DIHYDROPYRAZOLOPYRIMIDINONE
SI2459555T1 (sl) Postopek kristalizacije rivaroksabana
IL216648A0 (en) Crystalline forms of febuxostat
EP2407461A4 (en) PROCESS FOR PREPARING 1-ALKYL-5-BENZOYL-1H-TETRAZOL DERIVATIVES
EP2394955A4 (en) PROCESS FOR PRODUCING POLYCRYSTALLINE SILICON
HK1164698A1 (en) Crystalline forms of genistein
GB0902406D0 (en) Crystalline polymorphic form
SI2477964T1 (sl) Postopek za pripravo derivatov alfa-karboksamida
EP2479176A4 (en) PROCESS FOR THE PREPARATION OF ILOPERIDONE AND METHOD FOR ITS CRYSTALLIZATION
EP2456778A4 (en) PROCESS FOR PRODUCING FLUOROCYTIDINE DERIVATIVES
IL219138A0 (en) Process for the preparation of 4-sulfinyl-pyrazole derivatives
ZA201202097B (en) Crystalline forms of substituted pyrazolopyrimidines
ZA201204108B (en) Crystalline forms of bosentan salts and processes for their preparation
ZA201109045B (en) Crystalline form of pemirolast
EP2491044A4 (en) IMPROVED METHOD FOR THE PREPARATION OF CLOPIODOGREL BISULFATE IN THE CRYSTAL FORM 1
HUP0900788A2 (en) Process for producing 4-bromomethyl-biphenyl derivatives
IL209152A (en) Methanolic solvate of 2-cyano-2-deoxy-n4-palmitual-1-beta-d-arabinoporenecylcytocin, its crystalline form and processes for its preparation
HUP0900130A3 (en) Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
IL205857A0 (en) Processes for preparation of crystalline tigecyclline form ii
SI2376433T1 (sl) Kristalna oblika C tigeciklin dihidroklorida in postopki za njeno pripravo
HK1171759A1 (zh) 螺酮縮醇衍生物的製備方法
GB0907504D0 (en) Method of producing crystalline protein
SI2398784T1 (sl) Kristalna oblika febuksostata

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished